Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19
Description
Objective: Annexin A5 is a phosphatidylserine binding protein with anti-inflammatory, anticoagulant and anti-apoptotic properties. Preclinical studies have shown that annexin A5 inhibits pro-inflammatory responses and improves organ function and